Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation
✍ Scribed by Michael J. Comer; Michael J. Kearns; Jürgen Wahl; Michael Munster; Thomas Lorenz; Berthold Szperalski; Stefan Koch; Ulrich Behrendt; Herwig Brunner
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 288 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0920-9069
No coin nor oath required. For personal study only.
✦ Synopsis
A novel and powerful fermentation method is reported for the large-scale growth of mammalian cells and their secreted products. The system described illustrates many of the advantages of conventional batch fermentation processes but in addition has been shown to yield cell densities in excess of 1 x 10(7) cells/ml with concomitant increase in product concentration.
📜 SIMILAR VOLUMES
Hairy roots of tobacco (Nicotiana tabacum) used in clinical diagnosis, in commercial analyses, as were used to produce full-length murine IgG 1 monoclonal therapeutic agents, and as binding moieties in affinity antibody. The presence of heavy (␥) and light () chains separations. Large-scale producti
## Abstract Quality by design (QbD) is a scheme for the development, manufacture, and approval of pharmaceutical products. The end goal of QbD is to ensure product quality by building it into the manufacturing process. The main regulatory bodies are encouraging its implementation to the manufacture
An attempt has been made to mathematically describe and analyze monoclonal antibody (MAB) productivity of hybridoma cells, with particular emphasis on continuous cultures under unsteady-state conditions. A simple and unstructured general kinetic model that takes account of productivity loss during l